Business Context and Reporting Period
This Form 8-K was filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on April 1, 2019, reporting events occurring on March 26, 2019. The company is incorporated in Delaware and maintains its principal executive offices in Ashdod, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a securities transaction involving warrant exchanges.
Material Changes
On March 26, 2019, the Company exchanged all existing warrants with its financial advisor and two other entities for 51,001,499 new warrants. This transaction was exempt from registration under Section 3(a)(9) of the Securities Act of 1933. Key terms of the new warrants include:
- Exercise Price: $0.258
- Issuance Date: Deemed to be December 31, 2019
- Exercisability: Not exercisable until July 1, 2019
- Expiration: July 1, 2024
- Beneficial Ownership Limitations: Standard limit of 4.99%, extendable to 9.99% with 60 days' prior written notice.
Guidance, Risks, and Contingencies
The new warrants contain specific covenants requiring the Company to meet a 100% reserve requirement by July 1, 2019. If this requirement is not met, the Company must effect a reverse stock split of its issued and outstanding stock by August 14, 2019, to satisfy the reserve requirement.
Investor Verification Checklist
- Verify the total number of new warrants issued (51,001,499) and the exercise price ($0.258).
- Confirm the Company's ability to meet the 100% reserve requirement by July 1, 2019.
- Monitor for any announcement regarding a reverse stock split by August 14, 2019, if the reserve requirement is not met.
- Note the discrepancy between the requested company name (Glucotrack, Inc.) and the actual registrant (Integrity Applications, Inc.).